Diversity in HIV-1 envelope V1-V3 sequences early in infection reflects sequence diversity throughout the HIV-1 genome but does not predict the extent of sequence diversity during chronic infection

AIDS Research and Human Retroviruses

Volumn 22, Issue 5, 2006, Pages 430-437

  Sagar, Manish ^a,b,c   Kirkegaard, Erin ^a   Lavreys, Ludo ^b   Overbaugh, Julie ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; POL PROTEIN; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN;

ARTICLE; CHRONIC DISEASE; GENETIC VARIABILITY; GENOTYPE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS ENVELOPE; VIRUS GENOME;

CHRONIC DISEASE; COHORT STUDIES; FEMALE; GENES, ENV; GENES, GAG; GENES, POL; GENOME, VIRAL; HIV INFECTIONS; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; SEQUENCE ANALYSIS, PROTEIN; VARIATION (GENETICS); VIRAL ENVELOPE PROTEINS;

EID: 33646858570     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2006.22.430     Document Type: Article

References (24)

1. Coffin JM: HIV population dynamics in vivo: Implications for genetic variation, pathogenesis, and therapy. Science 1995;267:483-489.
2. Overbaugh J, and Bangham CR: Selection forces and constraints on retroviral sequence variation. Science 2001;292:1106-1109.
3. Zhu T, Mo H, Wang N, et al.: Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science 1993;261:1179-1181.
4. Zhang LQ, MacKenzie P, Cleland A, Holmes EC, Brown AJ, and Simmonds P: Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection. J Virol 1993;67:3345-3356.
5. Wolinsky SM, Wike CM, Korber BT, et al.: Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants. Science 1992;255:1134-1137.
6. Wolfs TF, Zwart G, Bakker M, and Goudsmit J: HIV-1 genomic RNA diversification following sexual and parenteral virus transmission. Virology 1992;189:103-110.
7. McNearney T, Hornickova Z, Markham R, et al.: Relationship of human immunodeficiency virus type 1 sequence heterogeneity to stage of disease. Proc Nad Acad Sci USA 1992;89:10247-10251.
8. Derdeyn CA, Decker JM, Bibollet-Ruche F, et al.: Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission. Science 2004;303:2019-2022.
9. Poss M, and Overbaugh J: Variants from the diverse virus population identified at seroconversion of a clade A human immunodeficiency virus type 1-infected woman have distinct biological properties. J Virol 1999;73:5255-5264.
10. Long EM, Martin HL Jr, Kreiss JK, et al.: Gender differences in HIV-1 diversity at time of infection. Nat Med 2000;6:71-75.
11. Kampinga GA, Simonon A, Van de Perre P, Karita E, Msellati P, and Goudsmit J: Primary infections with HIV-1 of women and their offspring in Rwanda: Findings of heterogeneity at seroconversion, coinfection, and recombinants of HIV-1 subtypes A and C. Virology 1997;227:63-76.
12. Sagar M, Lavreys L, Baeten JM, et al.: Infection with multiple human immunodeficiency virus type 1 variants is associated with faster disease progression. J Virol 2003;77:12921-12926.
13. Sagar M, Kirkegaard E, Long EM, et al.: Human immunodeficiency virus type 1 (HIV-1) diversity at time of infection is not restricted to certain risk groups or specific HIV-1 subtypes. J Virol 2004;78:7279-7283.
14. Delwart E, Magierowska M, Royz M, et al.: Homogeneous quasi-species in 16 out of 17 individuals during very early HIV-1 primary infection. AIDS 2002;16:189-195.
15. Learn GH, Muthui D, Brodie SJ, et al.: Virus population homogenization following acute human immunodeficiency virus type 1 infection. J Virol 2002;76:11953-11959.
16. Chohan B, Lang D, Sagar M, et al.: Selection for human immunodeficiency virus type 1 envelope glycosylation variants with shorter V1-V2 loop sequences occurs during transmission of certain genetic subtypes and may impact viral RNA levels. J Virol 2005;79:6528-6531.
17. Berger EA, Murphy PM, and Farber JM: Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease. Annu Rev Immunol 1999;17:657-700.
18. Rademeyer C, van Harmelen JH, Ramjee G, Karim SS, and Williamson C: Heterosexual transmission of multiple highly conserved viral variants in HIV-1 subtype C-infected seronegative women. AIDS 2004;18:2096-2098.
19. Martin HL Jr, Nyange PM, Richardson BA, et al.: Hormonal contraception, sexually transmitted diseases, and risk of heterosexual transmission of human immunodeficiency virus type 1. J Infect Dis 1998;178:1053-1059.
20. Rousseau CM, Nduati RW, Richardson BA, et al.: Association of levels of HIV-1-infected breast milk cells and risk of mother-to-child transmission. J Infect Dis 2004;190:1880-1888.
21. Nickle DC, Jensen MA, Gottlieb GS, et al.: Consensus and ancestral state HIV vaccines. Science 2003;299:1515-1518; author reply, 1515-1518.
22. Poss M, Rodrigo AG, Gosink JJ, et al.: Evolution of envelope sequences from the genital tract and peripheral blood of women infected with clade A human immunodeficiency virus type 1. J Virol 1998;72:8240-8251.
23. Baeten JM, and Overbaugh J: Measuring the infectiousness of persons with HIV-1: Opportunities for preventing sexual HIV-1 transmission. Curr HIV Res 2003;1:69-86.
24. Sagar M, Lavreys L, Baeten JM, et al.: Identification of modifiable factors that affect the genetic diversity of the transmitted HIV-1 population. AIDS 2004;18:615-619.